Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

A young woman's rare ovarian tumor was successfully removed, improving her hormonal symptoms.

Screen young women with menstrual issues, acne, or excess hair for high cortisol to avoid misdiagnosis.

Healthcare providers should know how to manage facial hair issues in women due to their social impact.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

PCOS is common in young women, especially those aged 21-30, and often involves symptoms like irregular periods, weight gain, and acne.

Women's acne improvement with antibiotics is not linked to signs of high male hormones.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Androgenetic alopecia in women needs more research and better management strategies.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Finasteride improves hair density and thickness in women with hair loss.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

WAA-QOL measures impact of hair loss on women's well-being.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Finasteride may help some women with hair loss, but better options exist.

Low prolactin in young women may increase heart and metabolism risks.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.